March 25, 2021 Press Releases

ICYMI: New York Times Opinion: Taxpayers Fund Research and Drug Companies Make a Fortune

WASHINGTON, D.C. — The New York Times today published an op-ed by David Mitchell, cancer patient and founder of Patients For Affordable Drugs, breaking down how the COVID-19 vaccine story makes it clearer than ever why Americans need our government to negotiate prices for all prescription drugs – including vaccines. Mitchell’s piece is in response to experts’ predictions that we will continue to need COVID-19 vaccines for years to come and vaccine makers’ warnings that they will raise vaccine prices in the future.

Click here to read the full article.



Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.